Alvea is a biotechnology startup dedicated to stopping future pandemics in their tracks. Alvea is dedicated to building technology that can deliver inhaled, shelf-stable RNA therapies and vaccines that patients can self-administer as easily as an inhaler. Using its technology, Alvea is actively developing a pan-variant COVID vaccine that’s dramatically easier to calibrate to new pathogens, manufacture, ship, and administer than anything that’s currently available for strengthening public health in an emergency.
Created by
Terrapinn is proud to be a member of isla. Working together to build sustainable events